Reg 74(5) Compliance Certificate Filing for Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.47

prior close

₹0.48

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.3% vs market

Biotechnology peers, median of 5sector-0.1%+0.1% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.1 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+1.3-1.3-0.1+0.1

Next day

+0.0+1.1-1.1+4.3-4.3

-2.1-1.7-0.4-1.4-0.8

+0.0-1.5+1.5+0.5-0.5

+0.0-0.6+0.6-1.4+1.4

+0.0-0.4+0.4-2.3+2.3

-2.1-1.4-0.7——

15d

-2.1pendingpending-4.3+2.1

—————

UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Ganesh Biotech India filed a quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 Sept 2026. The certificate from their Registrar Satellite Corporate Services confirms that no physical share certificates were received for dematerialization during the quarter. This is a routine regulatory filing.

Likely market impact

Routine compliance filing with no material impact. No physical share certificates were processed for demat this quarter.